Vista Pharmaceuticals (BOM:524711) GF Score: 47/100 (As of Aug. 06, 2026) — 18% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524711 Vista Pharmaceuticals Ltd BOM:524711
47 GF Score
Price ₹6.75
GF Value ₹6.13
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Vista Pharmaceuticals GF Score?

Vista Pharmaceuticals BOM:524711 +1.50% 47 GF Score is 47 as of Aug. 06, 2026, which is 18% below its 10-year median of 57.00. GuruFocus rates BOM:524711 with a GF Score™ of 47/100 and a GF Value™ of ₹6.13 (Fairly Valued). The stock has 4 warning signs investors should review.

Vista Pharmaceuticals has the GF Score of 47, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 3/10
3. Growth Rank : 4/10
4. GF Value Rank : 5/10
5. Momentum Rank : 1/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Vista Pharmaceuticals might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Vista Pharmaceuticals  (BOM:524711) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Vista Pharmaceuticals GF Score Related Terms

BOM:524711 vs ZTS: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vista Pharmaceuticals GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's GF Score distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's GF Score falls into.


BOM:524711
47GF Score
Vista Pharmaceuticals Ltd BOM:524711
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 47 mean?
Vista Pharmaceuticals (BOM:524711) has a GF Score of 47 as of Aug. 06, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Vista Pharmaceuticals and its competitors. This is 18% below median its historical median of 57.00. Over the past decade, Vista Pharmaceuticals' GF Score has ranged from 25.00 to 88.00.
Is Vista Pharmaceuticals' GF Score too high?
Vista Pharmaceuticals' current GF Score of 47 is 18% below median its 10-year median of 57.00. Over the past 10 years, this metric has ranged from a low of 25.00 to a high of 88.00. Overall, Vista Pharmaceuticals has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vista Pharmaceuticals' GF Score compare to ZTS?
Vista Pharmaceuticals' GF Score of 47 can be compared against companies in the Drug Manufacturers industry. Historically, Vista Pharmaceuticals' own GF Score has ranged from 25.00 to 88.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Vista Pharmaceuticals and its competitors. Vista Pharmaceuticals's current GF Score is 47, which is 18% below median its own 10-year median of 57.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vista Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Vista Pharmaceuticals (BOM:524711) is currently considered Fairly Valued. The stock's GF Value™ is ₹6.13, compared to a current price of ₹6.75 — trading 10.1% above its estimated fair value. The current GF Score is 47, which is 18% below median its 10-year median of 57.00. Vista Pharmaceuticals' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Vista Pharmaceuticals (BOM:524711), the current GF Score is 47 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vista Pharmaceuticals (BOM:524711) Overvalued in 2026?

Based on GuruFocus' analysis, Vista Pharmaceuticals stock appears to be overvalued. The current stock price of ₹6.75 is trading 10.1% above its estimated GF Value™ of ₹6.13. GuruFocus considers Vista Pharmaceuticals to be Fairly Valued.

Key valuation signals for BOM:524711:

  • GF Score: 47 (18% below median its 10-year median of 57.00)
  • GF Value™: ₹6.13 vs. price of ₹6.75 (10.1% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:524711 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vista Pharmaceuticals Business Description

Address Kakateeya Hills, Plot No. 104, Ravindra Co Operative Society, Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian company engaged in a single operating segment, which is the manufacturing of Pharmaceutical products. The company offers over-the-counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, and Indomethacin are the drugs offered by the company in a capsule dosage form. The company generates all of its operating revenue from sales within its domestic market.
47GF Score

Get the complete analysis for BOM:524711

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6.75
Price
₹6.13
GF Value